Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation (Q28576748)

From Wikidata

Jump to navigation Jump to search

scientific journal article

Language	Label	Description	Also known as
English	Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation	scientific journal article

Statements

scholarly article

1 reference

PubMed publication ID

31 January 2017

Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation (English)

1 reference

PubMed publication ID

31 January 2017

11

object named as

Ciro Indolfi

1 reference

PubMed publication ID

31 January 2017

author name string

Daniele Torella

1

1 reference

PubMed publication ID

31 January 2017

Antonio Curcio

2

1 reference

PubMed publication ID

31 January 2017

Cosimo Gasparri

3

1 reference

PubMed publication ID

31 January 2017

Valentina Galuppo

4

1 reference

PubMed publication ID

31 January 2017

Daniela De Serio

5

1 reference

PubMed publication ID

31 January 2017

Francesca C. Surace

6

1 reference

PubMed publication ID

31 January 2017

Anna Lucia Cavaliere

7

1 reference

PubMed publication ID

31 January 2017

Angelo Leone

8

1 reference

PubMed publication ID

31 January 2017

Carmela Coppola

9

1 reference

PubMed publication ID

31 January 2017

Georgina M. Ellison

10

1 reference

PubMed publication ID

31 January 2017

publication date

1 June 2007

1 reference

PubMed publication ID

31 January 2017

American Journal of Physiology Heart and Circulatory Physiology

1 reference

PubMed publication ID

31 January 2017

292

1 reference

PubMed publication ID

31 January 2017

6

1 reference

PubMed publication ID

31 January 2017

H2935–2943

1 reference

PubMed publication ID

31 January 2017

Effect of stent coating alone on in vitro vascular smooth muscle cell proliferation and apoptosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Genomics of in-stent restenosis: early insights into a complex disease.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

STATs: signal transducers and activators of transcription

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Membrane-bound protein kinase A inhibits smooth muscle cell proliferation in vitro and in vivo by amplifying cAMP-protein kinase A signals

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis).

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Propionyl-L-carnitine reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Oral Fludarabine

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

The JAK/STAT signaling pathway

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Tracking STAT nuclear traffic

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Preclinical restenosis models and drug-eluting stents: still important, still much to learn

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Fourth annual American College of Cardiology international lecture: a journey in the interventional field

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Coronary-artery stents

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

New frontiers in cardiology: drug-eluting stents: Part I.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

New frontiers in cardiology: drug-eluting stents: Part II.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Increased intimal hyperplasia in experimental vein graft stenting compared to arterial stenting: comparisons in a new rabbit model of stent injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2006

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28576748&oldid=2030841986"